DK1096952T3 - Polysaccharidvaccine mod stafylokok-infektioner - Google Patents

Polysaccharidvaccine mod stafylokok-infektioner

Info

Publication number
DK1096952T3
DK1096952T3 DK99934091T DK99934091T DK1096952T3 DK 1096952 T3 DK1096952 T3 DK 1096952T3 DK 99934091 T DK99934091 T DK 99934091T DK 99934091 T DK99934091 T DK 99934091T DK 1096952 T3 DK1096952 T3 DK 1096952T3
Authority
DK
Denmark
Prior art keywords
vaccine against
polysaccharide vaccine
staphylococcal infections
infections
against staphylococcal
Prior art date
Application number
DK99934091T
Other languages
English (en)
Inventor
Gerald B Pier
David Mckenney
Ying Wang
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Application granted granted Critical
Publication of DK1096952T3 publication Critical patent/DK1096952T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK99934091T 1998-07-15 1999-07-15 Polysaccharidvaccine mod stafylokok-infektioner DK1096952T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9311798P 1998-07-15 1998-07-15
PCT/US1999/016129 WO2000003745A2 (en) 1998-07-15 1999-07-15 Polysaccharide vaccine for staphylococcal infections

Publications (1)

Publication Number Publication Date
DK1096952T3 true DK1096952T3 (da) 2008-08-25

Family

ID=22237266

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99934091T DK1096952T3 (da) 1998-07-15 1999-07-15 Polysaccharidvaccine mod stafylokok-infektioner

Country Status (11)

Country Link
EP (2) EP1096952B1 (da)
JP (1) JP5490341B2 (da)
AT (1) ATE395931T1 (da)
AU (1) AU771563C (da)
CA (1) CA2333931C (da)
CY (1) CY1108542T1 (da)
DE (1) DE69938784D1 (da)
DK (1) DK1096952T3 (da)
ES (1) ES2308844T3 (da)
PT (1) PT1096952E (da)
WO (1) WO2000003745A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
AU2002305914A1 (en) * 2001-01-12 2002-10-21 Chiron Corporation Nucleic acid mucosal immunization
JP2005532415A (ja) 2001-12-11 2005-10-27 メルク　エンド　カムパニー　インコーポレーテッド スタフィロコッカス・アウレウスエキソポリサッカライド及び方法
US20060210555A1 (en) 2001-12-21 2006-09-21 Antigenics, Inc. Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
MXPA05005045A (es) 2002-11-12 2005-07-01 Brigham & Womens Hospital Vacuna de polisacarido para infecciones estafilococicas.
AU2003290867A1 (en) 2002-11-12 2004-06-03 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
WO2005103084A2 (en) * 2004-04-21 2005-11-03 The Brigham And Women's Hospital, Inc. Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof
AU2012205180B2 (en) * 2004-04-21 2014-10-09 Beth Israel Deaconess Medical Center, Inc. Poly-N-acetyl glucosamine(PNAG/DPNAG)-binding peptides and methods of use thereof
AU2014277807B2 (en) * 2004-04-21 2017-05-25 Beth Israel Deaconess Medical Center, Inc. Poly-N-acetyl glucosamine(PNAG/DPNAG)-binding peptides and methods of use thereof
EP2298340B1 (en) * 2004-09-22 2014-04-16 GlaxoSmithKline Biologicals S.A. Immunogenic composition for use in vaccination against staphylococcei
RU2419628C2 (ru) * 2004-09-22 2011-05-27 ГлаксоСмитКлайн Байолоджикалз с.а. Иммуногенная композиция для применения в вакцинации против стафилококков
MY148405A (en) * 2006-03-30 2013-04-30 Glaxosmithkline Biolog Sa Immunogenic composition
NZ591103A (en) 2008-07-21 2013-02-22 Brigham & Womens Hospital Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
US12397014B2 (en) 2019-02-05 2025-08-26 The Brigham And Women's Hospital, Inc. Polysaccharide compositions for use in treating filariasis
US10828360B1 (en) * 2020-02-04 2020-11-10 OneBioPharma, Inc. Methods for inhibiting biofilm formation

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3645090A (en) 1969-06-19 1972-02-29 Citizen Watch Co Ltd Day-date quick-adjuster for calender timepiece
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
US3832253A (en) 1973-03-21 1974-08-27 Baxter Laboratories Inc Method of making an inflatable balloon catheter
US4355023A (en) 1980-09-30 1982-10-19 The Massachusetts General Hospital Antibody fragment compositions and process
US4356170A (en) 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4470925A (en) 1982-05-05 1984-09-11 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US4667014A (en) 1983-03-07 1987-05-19 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
US4619828A (en) 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
US4462334A (en) 1982-08-19 1984-07-31 Kim Ho K Solar animal structure
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US4663160A (en) 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
CA1200416A (en) 1983-05-13 1986-02-11 Societe Des Produits Nestle S.A. Food process
US4808700A (en) 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
IT1187753B (it) 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
US5565354A (en) 1986-09-05 1996-10-15 Sandoz Ltd. Production of human monoclonal antibodies specific for hepatitis B surface antigen
FR2619122B1 (fr) * 1987-08-03 1990-03-09 Pasteur Institut Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
US5055455A (en) 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
FR2640628A1 (fr) * 1988-12-16 1990-06-22 Commissariat Energie Atomique Oligosaccharides lies (beta)-(1 -> 6) en particulier des 2-acetamido-2-desoxy-glucoses ou - galactoses et leur preparation
AU8507191A (en) 1990-08-29 1992-03-30 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
JPH04167172A (ja) 1990-10-31 1992-06-15 Nec Corp ベクトルプロセッサ
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor

Also Published As

Publication number Publication date
AU771563C (en) 2004-10-28
WO2000003745A2 (en) 2000-01-27
CY1108542T1 (el) 2014-04-09
EP1096952B1 (en) 2008-05-21
AU771563B2 (en) 2004-03-25
JP2002520374A (ja) 2002-07-09
EP1096952A2 (en) 2001-05-09
AU5000199A (en) 2000-02-07
CA2333931C (en) 2013-09-03
JP5490341B2 (ja) 2014-05-14
DE69938784D1 (de) 2008-07-03
CA2333931A1 (en) 2000-01-27
ES2308844T3 (es) 2008-12-01
PT1096952E (pt) 2008-08-27
WO2000003745A3 (en) 2000-04-20
EP1967203A1 (en) 2008-09-10
ATE395931T1 (de) 2008-06-15

Similar Documents

Publication Publication Date Title
CY1108542T1 (el) Εμβολιο πολυσακχαριτη για μολυνσεις απο σταφυλοκοκκο
WO2004043405A8 (en) Polysaccharide vaccine for staphylococcal infections
GT200000103A (es) Trifluorbutenos nematocidas.
BR0014470A (pt) Inibidores de fab i
DK0920421T3 (da) Isoxazolinderivater anvendelige som antimikrobielle midler
DE69130614D1 (de) Herbizide, substituierte aryl-haloalkylpyrazole
DK1075837T3 (da) Fremgangsmåde til fremstilling af vandige formuleringer til ophtalmisk anvendelse
GB0128996D0 (en) Organic compounds
BR0111520A (pt) Tiazina oxazolidinona usada como agente antimicrobiano
ES2243579T3 (es) Derivados de pirazolopirideno.
AU2005099A (en) Methods and compositions for the treatment and prevention of (staphylococcus aureus) infections
ES2186550A1 (es) Nuevos derivados de oxazolidinonas como antibacterianos.
WO2001074788A8 (en) 2-hydroxy-mutilin carbamate derivatives for antibacterial use
AU7001996A (en) Novel derivatives of cyclodepsipeptide PF1022 substance
EP0707000A4 (en) ALDOXIME DERIVATIVE AND AGRO-HORTICULTURAL BACTERICIDE
ATE432935T1 (de) N-(1,2,4-triazoloazinyl)thiophensulfonamid- verbindungen als herbizide
NO20062629L (no) Oksazolderivater av tetrackliner
BR0316086A (pt) N-sulfonil-4-metileno amino-3-hidróxi-2-piridonas como agente microbicida
TR199901017A2 (xx) B�cek ilac� terkibi.
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
DK0438813T3 (da) Nyt antibiotikum, deoxymulundocandin, en fremgangsmåde til dets fremstilling samt dets anvendelse som lægemiddel
IL161920A0 (en) Photochromic oxazine compounds and methods for their manufacture
EP1426374A4 (en) naphthyridine
EP2116552A3 (en) Peptides, derivatives thereof, process for producing the same, strain producing the same, and antiviral agent comprising the same as active ingredient
BRPI0411537A (pt) derivados de lincomicina que possuem atividade antibacteriana